Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

121 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Carotenoid intake and esophageal cancer risk: a meta-analysis.
Ge XX, Xing MY, Yu LF, Shen P. Ge XX, et al. Among authors: yu lf. Asian Pac J Cancer Prev. 2013;14(3):1911-8. doi: 10.7314/apjcp.2013.14.3.1911. Asian Pac J Cancer Prev. 2013. PMID: 23679292
A phase II trial of gemcitabine plus carboplatin in advanced transitional cell carcinoma of the urothelium.
Xu N, Zhang XC, Xiong JP, Fang WJ, Yu LF, Qian J, Zhang L. Xu N, et al. Among authors: yu lf. BMC Cancer. 2007 Jun 9;7:98. doi: 10.1186/1471-2407-7-98. BMC Cancer. 2007. PMID: 17559681 Free PMC article. Clinical Trial.
A Phase II trial of oxaliplatin, folinic acid, and 5-fluorouracil (FOLFOX4) as first-line chemotherapy in advanced colorectal cancer: a China single-center experience.
Xu N, Fang WJ, Zhang XC, Yu LF, Bao HY, Shi GM, Huang S, Shen P. Xu N, et al. Among authors: yu lf. Cancer Invest. 2007;25(7):599-605. doi: 10.1080/07357900701470739. Cancer Invest. 2007. PMID: 17882631 Clinical Trial.
[Analysis of serum metabonome of patients with breast cancer by gas chromatography-mass spectrometry].
Wang J, Yu LF, Shen P, Wang SF. Wang J, et al. Among authors: yu lf. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2009 Sep;38(5):478-84. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2009. PMID: 19830860 Chinese.
Phase II study of FOLFIRI regimen in patients with advanced colorectal cancer refractory to fluoropyrimidine and oxaliplatin.
Bao HY, Fang WJ, Zhang XC, Shi GM, Huang S, Yu LF, Chen J, Mou HB, Deng J, Shen P, Xu N. Bao HY, et al. Among authors: yu lf. Cancer Chemother Pharmacol. 2011 Jan;67(1):147-52. doi: 10.1007/s00280-010-1301-5. Epub 2010 Mar 11. Cancer Chemother Pharmacol. 2011. PMID: 20221830 Clinical Trial.
Predictive and prognostic value of ER-α36 expression in breast cancer patients treated with chemotherapy.
Yu L, Ke W, Wang Y, Ding W, Wang B, Huang S, Chen J, Wang X, Wang Z, Shen P. Yu L, et al. Steroids. 2014 Jun;84:11-6. doi: 10.1016/j.steroids.2014.03.003. Epub 2014 Mar 12. Steroids. 2014. PMID: 24632025 Retracted.
Analysis of urinary metabolites for breast cancer patients receiving chemotherapy by CE-MS coupled with on-line concentration.
Yu L, Jiang C, Huang S, Gong X, Wang S, Shen P. Yu L, et al. Clin Biochem. 2013 Aug;46(12):1065-1073. doi: 10.1016/j.clinbiochem.2013.05.049. Epub 2013 May 29. Clin Biochem. 2013. PMID: 23726806
A study of weekly docetaxel and carboplatin as first-line chemotherapy for advanced non-small cell lung cancer.
Jiang H, Zhang X, Chen J, Zhang L, Xiong J, Zhong L, Yu F, Qian J, Yu L, Wang X, Shi G, Deng J, Xu N. Jiang H, et al. Among authors: yu f, yu l. J Thorac Dis. 2014 Feb;6(2):79-85. doi: 10.3978/j.issn.2072-1439.2014.01.24. J Thorac Dis. 2014. PMID: 24605220 Free PMC article.
Primary squamous cell carcinoma of the esophagus initially presenting as a large retroperitoneal mass: A case diagnosed as cancer of unknown primary site.
Yu L, Ge X, Huang S, Wang Y, Shen P. Yu L, et al. Mol Clin Oncol. 2013 May;1(3):503-506. doi: 10.3892/mco.2013.79. Epub 2013 Feb 27. Mol Clin Oncol. 2013. PMID: 24649200 Free PMC article.
Successful response to the combination of immunotherapy and chemotherapy in cholangiocarcinoma with high tumour mutational burden and PD-L1 expression: a case report.
Mou H, Yu L, Liao Q, Hou X, Wu Y, Cui Q, Yan N, Ma R, Wang L, Yao M, Wang K. Mou H, et al. Among authors: yu l. BMC Cancer. 2018 Nov 12;18(1):1105. doi: 10.1186/s12885-018-5021-2. BMC Cancer. 2018. PMID: 30419854 Free PMC article.
121 results
Jump to page